Cargando…

Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity

The present study aimed to evaluate the feasibility of ultra-low (18)F-FDG activity in total-body PET/CT oncologic studies. Methods: Thirty patients with cancer were enrolled prospectively and underwent a total-body PET/CT scan 60 min after injection of an ultra-low (18)F-FDG activity (0.37 MBq/kg)....

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yan, Liu, Guobing, Yu, Haojun, Wang, Ying, Li, Chenwei, Tan, Hui, Chen, Shuguang, Gu, Jianying, Shi, Hongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157722/
https://www.ncbi.nlm.nih.gov/pubmed/34593593
http://dx.doi.org/10.2967/jnumed.121.262038
_version_ 1784718696214691840
author Hu, Yan
Liu, Guobing
Yu, Haojun
Wang, Ying
Li, Chenwei
Tan, Hui
Chen, Shuguang
Gu, Jianying
Shi, Hongcheng
author_facet Hu, Yan
Liu, Guobing
Yu, Haojun
Wang, Ying
Li, Chenwei
Tan, Hui
Chen, Shuguang
Gu, Jianying
Shi, Hongcheng
author_sort Hu, Yan
collection PubMed
description The present study aimed to evaluate the feasibility of ultra-low (18)F-FDG activity in total-body PET/CT oncologic studies. Methods: Thirty patients with cancer were enrolled prospectively and underwent a total-body PET/CT scan 60 min after injection of an ultra-low (18)F-FDG activity (0.37 MBq/kg). Of the 30 enrolled patients, 11 were diagnosed with colorectal cancer (CRC). PET raw data were acquired within 15 min and reconstructed using data from the first 1, 2, 4, 8, and 10 min and the entire 15 min (G1, G2, G4, G8, G10, and G15, respectively). Image quality was qualitatively assessed twice by 2 readers using a 5-point Likert scale. The Cohen κ-test was used to investigate the intra- and interreader agreement. The SUV(max) of lesions; the SUV(max), SUV(mean), and SD of the livers; the tumor-to-background ratio; and the signal-to-noise ratio were measured and compared. The acquisition time for a clinically acceptable image quality using an ultra-low-activity injection was determined. In a matched-pair study, 11 patients with CRC who received a full (18)F-FDG activity (3.7 MBq/kg) with an acquisition time of 2 min were selected retrospectively by matching sex, height, weight, body mass index, glucose level, uptake time, and pathologic types with the 11 CRC subjects in the prospective study. Qualitative and quantitative analyses were performed and compared between the 11 patients with CRC in the ultra-low-activity group and their matched full-activity controls. Results: Qualitative analysis of image quality showed good intra- and interreader agreements (all κ > 0.7). All the images acquired for 8 min or longer scored over 3 (indicating clinical acceptability). There was no significant difference in tumor-to-background ratio and liver signal-to-noise ratio among all the images acquired for 8 min or longer. In the matched study, no significant difference was found in the image quality score and quantitative parameters between the ultra-low-activity group with an 8-min acquisition and the full-activity group with a 2-min acquisition. Conclusion: An ultra-low (18)F-FDG activity with an 8-min acquisition in a total-body PET/CT study can achieve acceptable image quality equivalent to that in the full-activity group after a 2-min acquisition.
format Online
Article
Text
id pubmed-9157722
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Society of Nuclear Medicine
record_format MEDLINE/PubMed
spelling pubmed-91577222022-12-01 Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity Hu, Yan Liu, Guobing Yu, Haojun Wang, Ying Li, Chenwei Tan, Hui Chen, Shuguang Gu, Jianying Shi, Hongcheng J Nucl Med Clinical Investigation The present study aimed to evaluate the feasibility of ultra-low (18)F-FDG activity in total-body PET/CT oncologic studies. Methods: Thirty patients with cancer were enrolled prospectively and underwent a total-body PET/CT scan 60 min after injection of an ultra-low (18)F-FDG activity (0.37 MBq/kg). Of the 30 enrolled patients, 11 were diagnosed with colorectal cancer (CRC). PET raw data were acquired within 15 min and reconstructed using data from the first 1, 2, 4, 8, and 10 min and the entire 15 min (G1, G2, G4, G8, G10, and G15, respectively). Image quality was qualitatively assessed twice by 2 readers using a 5-point Likert scale. The Cohen κ-test was used to investigate the intra- and interreader agreement. The SUV(max) of lesions; the SUV(max), SUV(mean), and SD of the livers; the tumor-to-background ratio; and the signal-to-noise ratio were measured and compared. The acquisition time for a clinically acceptable image quality using an ultra-low-activity injection was determined. In a matched-pair study, 11 patients with CRC who received a full (18)F-FDG activity (3.7 MBq/kg) with an acquisition time of 2 min were selected retrospectively by matching sex, height, weight, body mass index, glucose level, uptake time, and pathologic types with the 11 CRC subjects in the prospective study. Qualitative and quantitative analyses were performed and compared between the 11 patients with CRC in the ultra-low-activity group and their matched full-activity controls. Results: Qualitative analysis of image quality showed good intra- and interreader agreements (all κ > 0.7). All the images acquired for 8 min or longer scored over 3 (indicating clinical acceptability). There was no significant difference in tumor-to-background ratio and liver signal-to-noise ratio among all the images acquired for 8 min or longer. In the matched study, no significant difference was found in the image quality score and quantitative parameters between the ultra-low-activity group with an 8-min acquisition and the full-activity group with a 2-min acquisition. Conclusion: An ultra-low (18)F-FDG activity with an 8-min acquisition in a total-body PET/CT study can achieve acceptable image quality equivalent to that in the full-activity group after a 2-min acquisition. Society of Nuclear Medicine 2022-06 /pmc/articles/PMC9157722/ /pubmed/34593593 http://dx.doi.org/10.2967/jnumed.121.262038 Text en © 2022 by the Society of Nuclear Medicine and Molecular Imaging. https://creativecommons.org/licenses/by/4.0/Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
spellingShingle Clinical Investigation
Hu, Yan
Liu, Guobing
Yu, Haojun
Wang, Ying
Li, Chenwei
Tan, Hui
Chen, Shuguang
Gu, Jianying
Shi, Hongcheng
Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
title Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
title_full Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
title_fullStr Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
title_full_unstemmed Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
title_short Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low (18)F-FDG Activity
title_sort feasibility of acquisitions using total-body pet/ct with an ultra-low (18)f-fdg activity
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157722/
https://www.ncbi.nlm.nih.gov/pubmed/34593593
http://dx.doi.org/10.2967/jnumed.121.262038
work_keys_str_mv AT huyan feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT liuguobing feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT yuhaojun feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT wangying feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT lichenwei feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT tanhui feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT chenshuguang feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT gujianying feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity
AT shihongcheng feasibilityofacquisitionsusingtotalbodypetctwithanultralow18ffdgactivity